Topics

"Horizon Phase Trial Evaluating Teprotumumab Active Thyroid Disease" Drugs and Medication Database

16:44 EST 11th December 2019 | BioPortfolio

Here are the most relevant "Horizon Phase Trial Evaluating Teprotumumab Active Thyroid Disease" Drugs and Medications that we have found in our database.

More Information about "Horizon Phase Trial Evaluating Teprotumumab Active Thyroid Disease" on BioPortfolio

We have published hundreds of Horizon Phase Trial Evaluating Teprotumumab Active Thyroid Disease news stories on BioPortfolio along with dozens of Horizon Phase Trial Evaluating Teprotumumab Active Thyroid Disease Clinical Trials and PubMed Articles about Horizon Phase Trial Evaluating Teprotumumab Active Thyroid Disease for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Horizon Phase Trial Evaluating Teprotumumab Active Thyroid Disease Companies in our database. You can also find out about relevant Horizon Phase Trial Evaluating Teprotumumab Active Thyroid Disease Drugs and Medications on this site too.

Showing "Horizon Phase Trial Evaluating Teprotumumab Active Thyroid Disease" Drugs and Medications, all 20

Probably Relevant

Amlodipine besylate [new horizon rx group, llc]

These highlights do not include all the information needed to use AMLODIPINE BESYLATE safely and effectively. See full prescribing information for AMLODIPINE BESYLATE. AMLODIPINE BESYLATE (AMLODIPINE BESYLATE) TABLET for ORAL use.Initial U.S. Approval: 19

Possibly Relevant

I 123 mini [anazaohealth corporation]

I-123 Mini Caps Medical Professional Information Sheet

Finasteride [new horizon rx group, llc]

FINASTERIDE TABLETS

Naproxen sodium [new horizon rx group, llc]

Naproxen Sodium Tablets, USP Rx Only

Baclofen [new horizon rx group, llc]

BACLOFEN TABLETS, USP

Thyrogen [genzyme corporation]

These highlights do not include all the information needed to use THYROGEN safely and effectively. See full prescribing information for THYROGEN. THYROGEN® (thyrotropin alfa for injection), for intramuscular injection Initial U.S. Approval: 1998

Metformin hydrochloride [new horizon rx group, llc]

Metformin Hydrochloride Tablets USP

Iclusig [millennium pharmaceuticals, inc.]

These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG(ponatinib) tablets, for oral use Initial U.S. Approval: 2012

I 131 mini [anazaohealth corporation]

I-131 Mini Caps Medical Professional Information Sheet

Migergot [horizon pharma inc.]

Ergotamine Tartrate and Caffeine Suppositories USP

Buphenyl [horizon pharma, inc.]

BUPHENYL (sodium phenylbutyrate) Tablets BUPHENYL (sodium phenylbutyrate) Powder

Trulicity [eli lilly and company]

These highlights do not include all the information needed to use TRULICITY safely and effectively. See full prescribing information for TRULICITY.TRULICITY (dulaglutide) injection, for subcutaneous useInitial U.S. Approval: 2014

Procysbi [horizon pharma inc.]

These highlights do not include all the information needed to use PROCYSBI safely and effectively. See Full Prescribing Information for PROCYSBI. PROCYSBI (cysteamine bitartrate) delayed-release capsules, for oral use Initial U.S. Approval: 1994

Sodium iodide i 123 [cardinal health 418, inc]

Sodium Iodide I 123 Diagnostic-Capsules for Oral Administration

Ravicti [horizon therapeutics, llc.]

These highlights do not include all the information needed to use RAVICTI safely and effectively. See full prescribing information for RAVICTI. RAVICTI (glycerol phenylbutyrate) oral liquid Initial U.S. Approval: 1996

Robinul [shionogi inc.]

Robinul and Robinul Forte

Sodium iodide i 123 [curium us llc]

Sodium Iodide I 123 Capsules Rx only Diagnostic -  For Oral Administration

Tizanidine [new horizon rx group, llc]

Tizanidine Tablets, USP Rx only

Bydureon [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use BYDUREON safely and effectively. See full prescribing information for BYDUREON. BYDUREON (exenatide extended-release) for injectable suspension, for subcutaneous useInitial U.S. Approval: 2

Bydureon bcise [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use BYDUREON BCISE safely and effectively. See full prescribing information for BYDUREON BCISE. BYDUREON BCISE™ (exenatide extended-release) injectable suspension, for subcutaneous use.Initia



Quick Search